Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.72)
# 757
Out of 5,078 analysts
394
Total ratings
40.1%
Success rate
16.9%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | n/a | $5.74 | - | 8 | Oct 23, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $19 → $23 | $2.80 | +721.43% | 6 | Oct 21, 2026 | |
| IRON Disc Medicine | Rated: Buy | $125 → $170 | $74.51 | +128.16% | 19 | Oct 19, 2026 | |
| RNA Atrium Therapeutics | Reiterated: Buy | $25 | $8.20 | +204.88% | 3 | Oct 14, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $61 → $72 | $29.25 | +146.15% | 28 | Oct 13, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $26.60 | $9.57 | +178.00% | 12 | Oct 7, 2026 | |
| STO: EGTX Egetis Therapeutics AB (publ) | Reiterated: Buy | kr 23.00 → kr 33.00 | kr 9.06 | +264.24% | 2 | Sep 29, 2026 | |
| PTCT PTC Therapeutics | Rated: Buy | $130 → $137 | $60.59 | +126.11% | 26 | Sep 21, 2026 | |
| ABEO Abeona Therapeutics | Reiterated: Buy | $28 → $30 | $4.40 | +581.82% | 12 | Sep 17, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Buy | $3 | $0.2817 | +964.96% | 11 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $39 | $15.65 | +149.20% | 19 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $5.92 | +339.19% | 4 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.5 → $28 | $5.93 | +372.18% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $109 → $119 | $70.65 | +68.44% | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.28 | +759.38% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $3.96 | +379.80% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $6.18 | +158.90% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $12 | $10.68 | +12.36% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $17.73 | +18.44% | 28 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $25 | $9.81 | +154.84% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 → $43 | $48.13 | -10.66% | 14 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $9.75 | +392.31% | 9 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $67 | $40.70 | +64.62% | 10 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.00 | +175.00% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $22.43 | - | 12 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $24 | $3.68 | +552.17% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $1.54 | +938.96% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.24 | +332.10% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $0.4354 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.47 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.00 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.5193 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $13.16 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.52 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $21.09 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $28 | $0.14 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.0001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.25 → $10 | $0.7178 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $2.07 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $0.7397 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.37 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0001 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.3641 | n/a | 1 | Nov 30, 2020 |
Phathom Pharmaceuticals
Oct 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.74
Upside: -
Lexeo Therapeutics
Oct 21, 2026
Reiterated: Buy
Price Target: $19 → $23
Current: $2.80
Upside: +721.43%
Disc Medicine
Oct 19, 2026
Rated: Buy
Price Target: $125 → $170
Current: $74.51
Upside: +128.16%
Atrium Therapeutics
Oct 14, 2026
Reiterated: Buy
Price Target: $25
Current: $8.20
Upside: +204.88%
Celldex Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $61 → $72
Current: $29.25
Upside: +146.15%
Eupraxia Pharmaceuticals Inc.
Oct 7, 2026
Reiterated: Buy
Price Target: $26.60
Current: $9.57
Upside: +178.00%
Egetis Therapeutics AB (publ)
Sep 29, 2026
Reiterated: Buy
Price Target: kr 23.00 → kr 33.00
Current: kr 9.06
Upside: +264.24%
PTC Therapeutics
Sep 21, 2026
Rated: Buy
Price Target: $130 → $137
Current: $60.59
Upside: +126.11%
Abeona Therapeutics
Sep 17, 2026
Reiterated: Buy
Price Target: $28 → $30
Current: $4.40
Upside: +581.82%
Mereo BioPharma Group
Sep 17, 2026
Reiterated: Buy
Price Target: $3
Current: $0.2817
Upside: +964.96%
Sep 17, 2026
Reiterated: Buy
Price Target: $33 → $39
Current: $15.65
Upside: +149.20%
Sep 15, 2026
Reiterated: Buy
Price Target: $26
Current: $5.92
Upside: +339.19%
Aug 14, 2026
Upgraded: Buy
Price Target: $3.5 → $28
Current: $5.93
Upside: +372.18%
Aug 12, 2026
Downgraded: Hold
Price Target: $109 → $119
Current: $70.65
Upside: +68.44%
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $1.28
Upside: +759.38%
Aug 11, 2026
Reiterated: Buy
Price Target: $19
Current: $3.96
Upside: +379.80%
Aug 6, 2026
Reiterated: Buy
Price Target: $16
Current: $6.18
Upside: +158.90%
Aug 5, 2026
Reiterated: Hold
Price Target: $30 → $12
Current: $10.68
Upside: +12.36%
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $17.73
Upside: +18.44%
Aug 5, 2026
Reiterated: Buy
Price Target: $34 → $25
Current: $9.81
Upside: +154.84%
Aug 4, 2026
Reiterated: Hold
Price Target: $38 → $43
Current: $48.13
Upside: -10.66%
Jul 16, 2026
Reiterated: Buy
Price Target: $48
Current: $9.75
Upside: +392.31%
Jul 9, 2026
Reiterated: Buy
Price Target: $63 → $67
Current: $40.70
Upside: +64.62%
Jun 25, 2026
Reiterated: Buy
Price Target: $11
Current: $4.00
Upside: +175.00%
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $22.43
Upside: -
Mar 19, 2026
Reiterated: Buy
Price Target: $15 → $24
Current: $3.68
Upside: +552.17%
Mar 10, 2026
Reiterated: Hold
Price Target: $16
Current: $1.54
Upside: +938.96%
Nov 21, 2025
Reiterated: Buy
Price Target: $14
Current: $3.24
Upside: +332.10%
Jul 1, 2024
Reiterated: Buy
Price Target: $6 → $7
Current: $0.4354
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $3.47
Upside: n/a
Feb 4, 2024
Reiterated: Buy
Price Target: $6
Current: $1.00
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.5193
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $13.16
Upside: n/a
Jun 28, 2023
Reiterated: Buy
Price Target: $27
Current: $1.52
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $21.09
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $3.5 → $28
Current: $0.14
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 21, 2022
Reiterated: Hold
Price Target: $4.25 → $10
Current: $0.7178
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $2.07
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $0.7397
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $10
Current: $0.37
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0001
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.3641
Upside: n/a